Arcturus Therapeutics Holdings (ARCT) EBITDA Margin Growth (3y) (2021 - 2026)
Arcturus Therapeutics Holdings (ARCT) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -40,178.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 530.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -137,151.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -137,151.00 |
| Dec 31, 2025 | -47,731.00 |
| Sep 30, 2025 | 18,538.00 |
| Jun 30, 2025 | 4,715.00 |
| Mar 31, 2025 | 92,786.00 |
| Dec 31, 2024 | 53,550.00 |
| Sep 30, 2024 | 220,272.00 |
| Jun 30, 2024 | 269,316.00 |
| Mar 31, 2024 | 257,853.00 |
| Dec 31, 2023 | 135,187.00 |
| Sep 30, 2023 | 86,436.00 |
| Jun 30, 2023 | -5,758.00 |
| Mar 31, 2023 | 43,272.00 |
| Dec 31, 2022 | 44,346.00 |
| Sep 30, 2022 | -3,977.00 |
| Jun 30, 2022 | -7,284.00 |
| Mar 31, 2022 | -81,751.00 |
| Dec 31, 2021 | -65,390.00 |
| Sep 30, 2021 | -209,510.00 |
| Jun 30, 2021 | -231,096.00 |